Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in wistar rats

Pulmonary Medicine

Volumn , Issue , 2013, Pages

  Verma, Ramesh ^a   Kushwah, Lokendra ^a   Gohel, Darpesh ^a   Patel, Manish ^a   Marvania, Tulsi ^a   Balakrishnan, Suresh ^b  

^a Jai Research Foundation   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893878025     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2013/921724     Document Type: Article

References (60)

1. Jules-Elysee K., White D. A., Bleomycin-induced pulmonary toxicity. Clinics in Chest Medicine 1990 11 1 1 20 2-s2.0-0025215373 (Pubitemid 20086836)
2. El-Medany A., Hagar H. H., Moursi M., At Muhammed R., El-Rakhawy F. I., El-Medany G., Attenuation of bleomycin-induced lung fibrosis in rats by mesna. European Journal of Pharmacology 2005 509 1 61 70 2-s2.0-13844271445 10.1016/j.ejphar.2004.12.001 (Pubitemid 40248786)
3. Kinnula V. L., Crapo J. D., Raivio K. O., Generation and disposal of reactive oxygen metabolites in the lung. Laboratory Investigation 1995 73 1 3 19 2-s2.0-0029051473
4. Tzurel A., Segel M. J., Or R., Goldstein R. H., Breuer R., Halofuginone does not reduce fibrosis in bleomycin-induced lung injury. Life Sciences 2002 71 14 1599 1606 2-s2.0-0037162961 10.1016/S0024-3205(02)01902-1 (Pubitemid 34874486)
5. Wang Q., Giri S. N., Hyde D. M., Li C., Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochemical Pharmacology 1991 42 5 1115 1122 2-s2.0-0025830935 10.1016/0006-2952(91)90296-H
6. El-Khatib A. S., Possible modulatory role of nitric oxide in lung toxicity induced in rats by chronic administration of bleomycin. Chemotherapy 2002 48 4-5 244 251 2-s2.0-0036906975
7. Yara S., Kawakami K., Kudeken N., Tohyama M., Teruya K., Chinen T., Awaya A., Saito A., FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clinical and Experimental Immunology 2001 124 1 77 85 2-s2.0-0035010919 10.1046/j.1365-2249.2001.01493.x (Pubitemid 32476937)
8. Atzori L., Chua F., Dunsmore S. E., Willis D., Barbarisi M., McAnulty R. J., Laurent G. J., Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol. Thorax 2004 59 3 217 223 2-s2.0-1542719757 10.1136/thx.2003.008979 (Pubitemid 38339878)
9. Filderman A. E., Genovese L. A., Lazo J. S., Alterations in pulmonary protective enzymes following systemic bleomycin treatment in mice. Biochemical Pharmacology 1988 37 6 1111 1116 2-s2.0-0023845583 (Pubitemid 18066466)
10. Galvan L., Huang C. H., Prestayko A. W., Inhibition of bleomycin-induced DNA breakage by superoxide dismutase. Cancer Research 1981 41 12 5103 5106 2-s2.0-0019787416 (Pubitemid 12196680)
11. Sriram N., Kalayarasan S., Sudhandiran G., Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulmonary Pharmacology & Therapeutics 2009 22 3 221 236 2-s2.0-67349202556 10.1016/j.pupt.2008.12.010
12. Soumyakrishnan S., Sudhandiran G., Daidzein attenuates inflammation and exhibits antifibrotic effect against bleomycin-induced pulmonary fibrosis in Wistar rats. Biomedicine & Preventive Nutrition 2011 1 4 236 244 2-s2.0-83855164029 10.1016/j.bionut.2011.09.005
13. Boots A. W., Haenen G. R. M. M., Bast A., Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology 2008 585 2-3 325 337 2-s2.0-43049176634 10.1016/j.ejphar.2008.03.008
14. Hollman P. C. H., Katan M. B., Dietary flavonoids: intake, health effects and bioavailability. Food and Chemical Toxicology 1999 37 9-10 937 942 2-s2.0-0032819772 10.1016/S0278-6915(99)00079-4 (Pubitemid 29481795)
15. Jagtap S., Meganathan K., Wagh V., Winkler J., Hescheler J., Sachinidis A., Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O- gallate, quercetin and curcumin against cancer and cardiovascular diseases. Current Medicinal Chemistry 2009 16 12 1451 1462 2-s2.0-65649137735 10.2174/092986709787909578
16. Skibola C. F., Smith M. T., Potential health impacts of excessive flavonoid intake. Free Radical Biology and Medicine 2000 29 3-4 375 383 2-s2.0-0033795879 10.1016/S0891-5849(00)00304-X
17. Chen C., Zhou J., Ji C., Quercetin: a potential drug to reverse multidrug resistance. Life Sciences 2010 87 11-12 333 338 2-s2.0-77956414625 10.1016/j.lfs.2010.07.004
18. Materska M., Perucka I., Antioxidant activity of the main phenolic compounds isolated from hot pepper fruit (Capsicum annuum L.). Journal of Agricultural and Food Chemistry 2005 53 5 1750 1756 2-s2.0-14744278639 10.1021/jf035331k (Pubitemid 40326270)
19. Flora S. J. S., Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxidative Medicine and Cellular Longevity 2009 2 4 191 206 2-s2.0-77953455188 10.4161/oxim.2.4.9112
20. Walter N., Collard H. R., King T. E. Jr., Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proceedings of the American Thoracic Society 2006 3 4 330 338 2-s2.0-33744901434 10.1513/pats.200602-016TK (Pubitemid 43845410)
21. Gad S. C., Weil C. S., Hayes A. W., Statistics for toxicology. Principles and Methods of Toxicology 1994 3rd New York, NY, USA Raven Press 221 274
22. Teixeira K. C., Soares F. S., Rocha L. G. C., Silveira P. C. L., Silva L. A., Valença S. S., Pizzol F. D., Streck E. L., Pinho R. A., Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulmonary Pharmacology & Therapeutics 2008 21 2 309 316 2-s2.0-39749169707 10.1016/j.pupt.2007.07.006 (Pubitemid 351312673)
23. Wang H.-D., Yamaya M., Okinaga S., Jia Y.-X., Kamanaka M., Takahashi H., Guo L.-Y., Ohrui T., Sasaki H., Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. American Journal of Respiratory and Critical Care Medicine 2002 165 3 406 411 2-s2.0-0036468708 (Pubitemid 34118517)
24. Tang Y., Gao C., Xing M., Li Y., Zhu L., Wang D., Yang X., Liu L., Yao P., Quercetin prevents ethanol-induced dyslipidemia and mitochondrial oxidative damage. Food and Chemical Toxicology 2012 50 5 1194 1200 2-s2.0-84858167192 10.1016/j.fct.2012.02.008
25. Edwards C. A., O'Brien W. D. Jr., Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clinica Chimica Acta 1980 104 2 161 167 2-s2.0-0018869798 10.1016/0009-8981(80)90192-8 (Pubitemid 10071550)
26. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
27. Kakkar P., Das B., Viswanathan P. N., A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry and Biophysics 1984 21 2 130 132 2-s2.0-0021681627 (Pubitemid 15207169)
28. Luck H., Bergmeyer H. U., A spectrophotometric method for the estimation of catalase. Methods of Enzymatic Analysis 1963 New York, NY, USA Academic Press 886 887
29. Szapiel S. V., Elson N. A., Fulmer J. D., Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. American Review of Respiratory Disease 1979 120 4 893 899 2-s2.0-0018629834 (Pubitemid 10194957)
30. Sleijfer S., Bleomycin-induced pneumonitis. Chest 2001 120 2 617 624 2-s2.0-0034827655 10.1378/chest.120.2.617 (Pubitemid 32881285)
31. Coker R. K., Laurent G. J., Pulmonary fibrosis: cytokines in the balance. European Respiratory Journal 1998 11 6 1218 1221 2-s2.0-0031833250 10.1183/09031936.98.11061218 (Pubitemid 28298579)
32. Keane M. P., Belperio J. A., Burdick M. D., Strieter R. M., IL-12 attenuates bleomycin-induced pulmonary fibrosis. American Journal of Physiology: Lung Cellular and Molecular Physiology 2001 281 1 L92 L97 2-s2.0-0034804380
33. Cooper J. A. D. Jr., Pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology 2000 22 5 520 523 10.1165/ajrcmb.22.5.f185
34. Zhou X.-M., Zhang G.-C., Li J.-X., Hou J., Inhibitory effects of Hu-Qi-Yin on the bleomycin-induced pulmonary fibrosis in rats. Journal of Ethnopharmacology 2007 111 2 255 264 2-s2.0-34047096498 10.1016/j.jep.2006.11. 029 (Pubitemid 46528074)
35. Gazdhar A., Fachinger P., van Leer C., Pierog J., Gugger M., Friis R., Schmid R. A., Geiser T., Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. American Journal of Physiology: Lung Cellular and Molecular Physiology 2007 292 2 L529 L536 2-s2.0-33847040423 10.1152/ajplung.00082.2006
36. Zhao L., Wang X., Chang Q., Xu J., Huang Y., Guo Q., Zhang S., Wang W., Chen X., Wang J., Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. European Journal of Pharmacology 2010 627 1-3 304 312 2-s2.0-73449146238 10.1016/j.ejphar.2009.11.007
37. Daba M. H., Abdel-Aziz A.-A. H., Moustafa A. M., Al-Majed A. A., Al-Shabanah O. A., El-Kashef H. A., Effects of L-carnitine and ginkgo biloba extract (EGb 761) in experimental bleomycin-induced lung fibrosis. Pharmacological Research 2002 45 6 461 467 2-s2.0-0036418572 10.1006/phrs.2002.0985 (Pubitemid 35304494)
38. Pardo A., Ruiz V., Arreola J. L., Ramírez R., Cisneros-Lira J., Gaxiola M., Barrios R., Kala S. V., Lieberman M. W., Selman M., Bleomycin-induced pulmonary fibrosis is attenuated in γ -glutamyl transpeptidase-deficient mice. American Journal of Respiratory and Critical Care Medicine 2003 167 6 925 932 2-s2.0-0037445289 10.1164/rccm.200209-1007OC (Pubitemid 36801783)
39. Serrano-Mollar A., Closa D., Prats N., Blesa S., Martinez-Losa M., Cortijo J., Estrela J. M., Morcillo E. J., Bulbena O., In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. British Journal of Pharmacology 2003 138 6 1037 1048 2-s2.0-0037361993 10.1038/sj.bjp.0705138 (Pubitemid 36459826)
40. Liang X., Tian Q., Wei Z., Liu F., Chen J., Zhao Y., Qu P., Huang X., Zhou X., Liu N., Tian F., Tie R., Liu L., Yu J., Effect of Feining on bleomycin-induced pulmonary injuries in rats. Journal of Ethnopharmacology 2011 134 3 971 976 2-s2.0-79954425493 10.1016/j.jep.2011.02.008
41. Grande N. R., Peao M. N. D., De Sa C. M., Aguas A. P., Lung fibrosis induced by bleomycin: structural changes and overview of recent advances. Scanning Microscope 1998 12 487 494
42. Sogut S., Ozyurt H., Armutcu F., Kart L., Iraz M., Akyol O., Ozen S., Kaplan S., Temel I., Yildirim Z., Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. European Journal of Pharmacology 2004 494 2-3 213 220 2-s2.0-2942722440 10.1016/j.ejphar.2004.04.045 (Pubitemid 38798107)
43. de Boer V. C. J., Dihal A. A., van der Woude H., Arts I. C. W., Wolffram S., Alink G. M., Rietjens I. M. C. M., Keijer J., Hollman P. C. H., Tissue distribution of quercetin in rats and pigs. Journal of Nutrition 2005 135 7 1718 1725 2-s2.0-22144495044 (Pubitemid 40980724)
44. Wei X., Han J., Chen Z.-Z., Qi B.-W., Wang G.-C., Ma Y.-H., Zheng H., Luo Y.-F., Wei Y.-Q., Chen L.-J., A phosphoinositide 3-kinase- γ inhibitor, AS605240 prevents bleomycin-induced pulmonary fibrosis in rats. Biochemical and Biophysical Research Communications 2010 397 2 311 317 2-s2.0-77955480020 10.1016/j.bbrc.2010.05.109
45. Gong L.-K., Li X.-H., Wang H., Zhang L., Chen F.-P., Cai Y., Qi X.-M., Liu L.-L., Liu Y.-Z., Wu X.-F., Huang C.-G., Ren J., Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats. Journal of Ethnopharmacology 2005 96 3 537 544 2-s2.0-21644448511 10.1016/j.jep.2004.09.046 (Pubitemid 41556606)
46. Razzaque M. S., Taguchi T., Pulmonary fibrosis: cellular and molecular events. Pathology International 2003 53 3 133 145 2-s2.0-0037353255 10.1046/j.1440-1827.2003.01446.x (Pubitemid 36384689)
47. Verma R., Brahmankar M., Kushwah L., Suresh B., Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats. Environmental Toxicology and Pharmacology 2013 36 3 769 778 10.1016/j.etap.2013.07.011
48. Kalayarasan S., Sriram N., Sudhandiran G., Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-κB, TNF-α and IL-1 β Life Sciences 2008 82 23-24 1142 1153 2-s2.0-43849095954 10.1016/j.lfs.2008.03.018
49. Ortiz L. A., Champion H. C., Lasky J. A., Gambelli F., Gozal E., Hoyle G. W., Beasley M. B., Hyman A. L., Friedman M., Kadowitz P. J., Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-κB and AP-1. American Journal of Physiology: Lung Cellular and Molecular Physiology 2002 282 6 L1209 L1221 2-s2.0-0036083866 (Pubitemid 34654576)
50. Yoon J. S., Chae M. K., Jang S. Y., Lee S. Y., Lee E. J., Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of graves orbitopathy. Investigative Ophthalmology & Visual Science 2012 53 9 5921 5929 10.1167/iovs.12-9646
51. Rosas I. O., Richards T. J., Konishi K., Zhang Y., Gibson K., Lokshin A. E., Lindell K. O., Cisneros J., MacDonald S. D., Pardo A., Sciurba F., Dauber J., Selman M., Gochuico B. R., Kaminski N., MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Medicine 2008 5 4, article e93 0623 0633 2-s2.0-43249084804 10.1371/journal.pmed.0050093 (Pubitemid 351649261)
52. Pardo A., Selman M., Role of matrix metaloproteases in idiopathic pulmonary fibrosis. Fibrogenesis & Tissue Repair 2012 5, article S9 supplement 1
53. Zuo F., Kaminski N., Eugui E., Allard J., Yakhini Z., Ben-Dor A., Lollini L., Morris D., Kim Y., DeLustro B., Sheppard D., Pardo A., Selman M., Heller R. A., Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proceedings of the National Academy of Sciences of the United States of America 2002 99 9 6292 6297 2-s2.0-18344396051 10.1073/pnas.092134099 (Pubitemid 34493305)
54. Arafa H. M. M., Abdel-Wahab M. H., El-Shafeey M. F., Badary O. A., Hamada F. M. A., Anti-fibrotic effect of meloxicam in a murine lung fibrosis model. European Journal of Pharmacology 2007 564 1-3 181 189 2-s2.0-34250670436 10.1016/j.ejphar.2007.02.065 (Pubitemid 46946863)
55. Jovanovic S. V., Steenken S., Simic M. G., Hara Y., Evans C. R., Packer L., Antioxidant properties of flavonoids: reduction potentials and electron transfer reactions of flavonoid radicals. Flavonoids in Health and Disease 1998 New York, NY, USA Marcel Dekker 137 161
56. Kawada N., Seki S., Inoue M., Kuroki T., Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells. Hepatology 1998 27 5 1265 1274 2-s2.0-0031969571 10.1002/hep.510270512 (Pubitemid 28227853)
57. Huk I., Brovkovych V., Nanobash Vili J., Weigel G., Neumayer C., Partyka L., Patton S., Malinski T., Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. The British Journal of Surgery 1998 85 8 1080 1085 2-s2.0-0031876672 10.1046/j.1365-2168.1998.00787.x (Pubitemid 28360771)
58. Kumar P., Sharma S., Khanna M., Raj H. G., Effect of quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. International Journal of Experimental Pathology 2003 84 3 127 133 2-s2.0-0141504429 10.1046/j.1365-2613.2003.00344.x (Pubitemid 37188255)
59. 2-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. International Journal of Biological Sciences 2011 7 6 869 880 2-s2.0-79960976740
60. Madala S. K., Schmidt S., Davidson C., Ikegami M., Wert S., Hardie W. D., MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. American Journal of Respiratory Cell and Molecular Biology 2012 46 3 380 388 2-s2.0-84857739552 10.1165/rcmb.2011-0237OC